NASDAQ:VAXX
Vaxxinity, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.vaxxinity.comipo date
Nov 11, 2021
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that targets toxic forms of aggregate...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus